Coffee, rich in polyphenolic compounds like chlorogenic acid (CGA), caffeic acid (CAA), cafestol, melanoidins and trigonelline, has been recognized as a dominant source of CGA in various studies. Previous studies suggest that CGA in coffee can positively impact blood pressure, lipid profile, glycemia and insulin resistance.
It’s possible your morning cup of coffee can do more than just wake you up. According to a recent study published in BMC’s Cell & Bioscience journal, drinking 1 to 2 cups per day could curb COVID-19 infection, offering potential protection against various COVID strains like the Omicron variant.
Since late 2020, many COVID variants have spread globally, with recent reports revealing the Omicron variant has at least 32 mutations in its spike protein, double that of the Delta variant.
As COVID-19 boosters evolve to address the increasing amount of cases, it's important to note that diet, along with the latest preventive measures, plays a role in combating COVID infection.
Research has suggested that engaging in regular physical activity and maintaining a diet rich in polyphenols can affect the immune system, change immune escape properties and reduce the risk of severe COVID.
However, previous studies have also found that coffee consumption is associated with reduced COVID risk.
Coffee, also rich in polyphenolic compounds like chlorogenic acid (CGA), caffeic acid (CAA), cafestol, melanoidins and trigonelline, has been recognized as a dominant source of CGA in various studies.
Previous studies suggest that CGA in coffee can positively impact blood pressure, lipid profile, glycemia and insulin resistance, contributing to the improvement of metabolic syndrome and enhancing metabolism, inflammation, cardiovascular health and liver function.
Though, further studies have yet to demonstrate the exact mechanism that coffee stops the binding of COVID to host cells.
In the BMC human trial study, researchers observed data from the UK Biobank to find that coffee can be a new strategy to reduce COVID infection by blocking spike protein ACE2 interaction, slowing down TMPRSS2 and CTSL activity and ridding the protein level of TMPRSS2 and ACE2.
Using the HRMS-exploring-recombination-examining method, researchers discovered that isochlorogenic acid A, B, and C in coffee restrict COVID infection (43–54% efficiency), as well as decaffeinated coffee.
In the trial of 64 people, consuming 1–2 cups of coffee per day proved effective in stopping entry for multiple COVID variants.
However, for the Omicron variant, previous articles pointed out that this variant has more mutations and a higher ability of immune escape than other variants. This results in many strategies potentially being ineffective or having poor responses to stop the infection from the Omicron variant.
Despite that, authors of the BMC study discovered that consuming coffee within 6 hours is crucial, with a recommendation to have another cup after this period for better chances to stop the infection.
Authors propose a strategic coffee-drinking plan as a preventive measure for individuals in the post-COVID era.
The Challenges, Strategies of COVID-19 Misinformation Interventions
November 16th 2023COVID-19 misinformation interventions should involve public health experts, establish consistent outcome measures and more to address health misinformation at individual, community and systems levels, according researchers of a recent study.
Read More
In this episode, Peter Wehrwein, managing editor of Managed Healthcare Executive, speaks with Dr. Rodrigo Cerda. Dr. Cerda has been recently promoted to the position of senior vice president of health services and chief medical officer of Independence Blue Cross in Philadelphia. He is also a member of Managed Healthcare Executive’s editorial advisory board. Peter and Dr. Cerda discuss his new role at the Independence Blue Cross, what it means to be a chief medical officer at an insurer these days, valued-based care, social determinants of health, and, of course, the pandemic.
Listen
The risk of stroke is not as likely for adults 65 years and above who have taken the Pfizer-BioNTech and Moderna COVID-19 bivalent vaccines. However, there may be an elevated risk of stroke when COVID boosters are paired with high-dose flu vaccines, particularly in adults 85-years-old and above.
Read More
Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.
Listen
The Latest on Long COVID — Most Prevalent Symptoms to Research Underway | IDWeek 2023
October 12th 2023At this year’s ID Week conference in Boston, Igho Ofotokun, MD, MSc, FIDSA, Grady Distinguished Professor of Medicine at the Emory University School of Medicine, shared the latest data that COVID-19 research team, RECOVER, has gathered on Long COVID and its symptoms.
Read More
HHS Grants $45 Million to Long COVID Clinics to Transform Healthcare for Underserved Populations
September 21st 2023There are nine grant awards of $1 million each for up to 5 years — totaling to overall $45 million in grants — that would mainly support underserved, rural, vulnerable, and minority populations that are disproportionately impacted by the effects of Long COVID
Read More